Come up with a name for your new list and we'll add to it:
Stellar Biotechnologies raised a round of funding on March 06, 2009. Investors include
National Science Foundation.
Stellar Biotechnologies (NASDAQ: SBOT) specializes in Keyhole Limpet Hemocyanin (KLH) protein and is focused in the rapidly-evolving field of immunotherapy. KLH is an important immune-stimulating mole…